Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBI-087 in active rheumatoid arthritis
NCT01008852Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of sbi-087 in rheumatoid arthritis (RA), sponsored by Pfizer. Started Dec 2009; status: completed.
02
Drugs
sbi-087
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01008852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008852.